Tagged companies

haematology

2 companies

CRISPR Therapeutics

Zug, Switzerland · 2013

Gene-editing biotech developing transformative treatments for haematological disorders, oncology, and diabetes using CRISPR-Cas9 technology.

High

Beam Therapeutics

Cambridge, MA, USA · 2017

Pioneer in precision base editing, developing treatments for sickle cell disease, blood cancers, and other serious genetic conditions.

High
×